PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,755,937 | -1.5% | 504,956 | +2.9% | 0.00% | 0.0% |
Q2 2023 | $8,893,133 | +222.5% | 490,791 | +373.4% | 0.00% | +100.0% |
Q1 2023 | $2,757,542 | +75.3% | 103,667 | +27.4% | 0.00% | – |
Q4 2022 | $1,572,921 | +33.8% | 81,372 | +44.5% | 0.00% | – |
Q3 2022 | $1,176,000 | +289.4% | 56,301 | +49.1% | 0.00% | – |
Q2 2022 | $302,000 | -79.8% | 37,761 | -82.3% | 0.00% | – |
Q1 2022 | $1,498,000 | -51.4% | 213,669 | -6.5% | 0.00% | -100.0% |
Q4 2021 | $3,084,000 | -18.7% | 228,451 | +1.6% | 0.00% | 0.0% |
Q3 2021 | $3,795,000 | -39.7% | 224,820 | +4.0% | 0.00% | 0.0% |
Q2 2021 | $6,293,000 | -28.0% | 216,122 | -2.7% | 0.00% | -50.0% |
Q1 2021 | $8,735,000 | +216.3% | 222,092 | +82.7% | 0.00% | +100.0% |
Q4 2020 | $2,762,000 | +0.6% | 121,536 | +0.3% | 0.00% | 0.0% |
Q3 2020 | $2,745,000 | – | 121,214 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 5,839,160 | $98,565,000 | 18.71% |
CHI Advisors LLC | 2,484,724 | $41,942,000 | 12.24% |
TRV GP IV, LLC | 2,132,867 | $36,003,000 | 8.17% |
Bond & Devick Financial Network, Inc. | 120,160 | $2,028,000 | 1.68% |
Fernwood Investment Management, LLC | 166,447 | $2,810,000 | 0.96% |
Redmile Group, LLC | 3,083,501 | $52,049,000 | 0.91% |
HARVARD MANAGEMENT CO INC | 562,379 | $9,493,000 | 0.56% |
Grace Capital | 48,058 | $808,000 | 0.50% |
Eventide Asset Management | 2,183,238 | $36,853,000 | 0.49% |
Cormorant Asset Management, LP | 482,413 | $8,143,000 | 0.33% |